Form D Explorer

Source evidence

GelSana Therapeutics, Inc. · 0002002665-26-000004

D/A filed Oct. 8, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
AURORA
street1
12635 E MONTVIEW BLVD STE 326
zipCode
80045
entityName
GelSana Therapeutics, Inc.
entityType
Corporation
stateOrCountry
CO
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold4352701number4352701/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount4931726number4931726/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count33number33/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 6523fcb095fb479b2ff3cef6b0369a8d7c250e3012ad1bc393f4fcead9e6b9c9. This proves extraction identity, not the accuracy of the filer's claims.